Company profile: Abraxis
1.1 - Company Overview
Company description
- Provider of rapid test kits and related products for environmental, water quality, food/agriculture, and life sciences, including ELISA, lateral flow, and magnetic particle assay kits; standards and QC materials (certified reference materials and check samples); lab testing equipment (automated analyzers and manual test strip readers); AbraMag magnetic beads; and BACGro dehydrated and prepared culture media.
Products and services
- Rapid Test Kits: Laboratory-grade assays that rapidly detect targets in water quality, environmental, and food/agriculture samples using ELISA, Lateral Flow, and Magnetic Particle assays engineered for swift screening
- Lab Testing Equipment: Industrial-grade analytical instruments and supplies for sample preparation and measurement, delivering automated analyzers and manual test strip readers to streamline laboratory workflows for accurate assessments
- Standards and QC Materials: Research-grade analytical standards, certified reference materials, and check samples that supply consistent quality control for testing needs across environmental, food safety, and life sciences applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abraxis
TriVirix
HQ: United States
Website
- Description: Provider of U.S.-based manufacturing and design for electro-mechanical, medical, diagnostic, analytical, and life-science devices, offering ribo printers, point-of-care blood testing analyzers, volumetric infusion pumps, and vital sign or conscious sedation monitors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriVirix company profile →
LightDeck
HQ: United States
Website
- Description: Provider of on-the-spot diagnostic products delivering fast, accurate, low-cost, lab-quality results in minutes via a proprietary laser waveguide platform. Offerings include a 5-minute COVID-19 antigen test; developing hormone, host-response, and cardiac marker panels; environmental tests for harmful algae blooms; and point-of-care veterinary diagnostics with Heska.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LightDeck company profile →
Healeon Medical
HQ: United States
Website
- Description: Provider of next-generation protocols that improve isolation of regenerative cells and the Healeon PRP Blood Separation Product Suite, a collection of products for separating platelet-rich plasma (PRP) from blood for regenerative medicine applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Healeon Medical company profile →
DCS Diagnostics
HQ: Germany
Website
- Description: Provider of diagnostic devices as a pharmaceutical firm, specializing in the sale and development of devices for human use.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DCS Diagnostics company profile →
Interpace Biosciences
HQ: New Zealand
Website
- Description: Provider of molecular diagnostics and support services: PancraGEN assesses pancreaticobiliary cancer risk via DNA analysis; ThyGeNEXT uses NGS to identify mutations in thyroid nodules; ThyraMIR classifies indeterminate nodules with microRNA; RespriDx differentiates new primary lung tumors from metastases; BarreGen predicts Barrett’s Esophagus progression; NAVIGATOR aids testing access and financing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Interpace Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abraxis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abraxis
2.2 - Growth funds investing in similar companies to Abraxis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abraxis
4.2 - Public trading comparable groups for Abraxis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →